|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.80 INR | -3.95% |
|
+2.38% | +4.04% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 |
|---|---|
| Market Cap 1 | 91.84 |
| Change | - |
| Enterprise Value (EV) 1 | 61.1 |
| Change | - |
| P/E | 21.2x |
| PBR | 1.04x |
| PEG | -1.1x |
| Capitalization / Revenue | 1.12x |
| EV / Revenue | 0.74x |
| EV / EBITDA | 7.34x |
| EV / EBIT | 16x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | 1.896 |
| Distribution rate | - |
| Net sales 1 | 82.35 |
| EBITDA 1 | 8.319 |
| EBIT 1 | 3.821 |
| Net income 1 | 3.947 |
| Net Debt 1 | -30.75 |
| Reference price 2 | 40.24 |
| Nbr of stocks (in thousands) | 2,282 |
| Announcement Date | 26/8/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.1M | |
| -157.47x | 13.04x | -178.47x | -.--% | 39B | |
| 18.86x | 1.82x | 10.53x | 1.07% | 22.93B | |
| 16.39x | 1.29x | 7.35x | 5.31% | 7.13B | |
| 304x | - | - | - | 4.66B | |
| 54.28x | 9.59x | 33.67x | 0.85% | 2.91B | |
| -23.06x | - | - | - | 2.05B | |
| -31.97x | - | - | -.--% | 1.86B | |
| 30.62x | 1.09x | 9.09x | 0.82% | 1.75B | |
| 12.25x | 1.28x | 5.04x | 6.17% | 1.63B | |
| Average | 24.88x | 4.69x | -18.80x | 2.03% | 8.39B | |
| Weighted average by Cap. | -48.26x | 7.85x | -86.85x | 0.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
